Literature DB >> 24868876

5-(Hydroxymethyl)-2-furaldehyde inhibits adipogenic and enhances osteogenic differentiation of rat bone mesenchymal stem cells.

Xiang-Ling Tan, Yan-Hong Zhang, Jian-Ping Cai, Li-Hua Zhu, Wen-Jie Ge, Xian Zhang.   

Abstract

Eucommiae Cortex (Eucommia ulmoides Oliver Bark) has been used for anti-osteoporosis usually as an ethnic drug for hundred years in China. In this study, a bioactive compound, 5-(hydroxymethyl)-2-furaldehyde (5-HMF), was isolated from Eucommiae Cortex. We found that after rat bone mesenchymal stem cells (bMSCs) were induced by 5-HMF at the concentration of 0.05, 0.10 and 0.20 microg/mL in the normal medium for 7 and 14 days, the mRNA expression of ALP, COL1alpha1 (7 days only), OCN and OPN increased. However, in the adipogenic induction medium (AIM), the mRNA expression of PPARgamma, FABP4, C/EBPalpha and LPL decreased with the 5-HMF treatment. Mineralized nodule formations were enhanced after bMSCs were induced by 5-HMF for 14 and 21 days in normal medium. In the AIM medium, 5-HMF not only inhibited the formation of adipose cells obviously, but also stimulated the mineralized nodule formation after induced for 21 days. These results indicated that 5-HMF was a powerful inhibitor of adipogenesis and enhancer of osteoblastogenesis. It may be one of the constituents contributing to anti-osteoporosis in Eucommiae Cortex.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24868876

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  8 in total

1.  Therapeutic effect of Shinkiwhan, herbal medicine, regulates OPG/RANKL/RANK system on ovariectomy-induced bone loss rat.

Authors:  Il-Bok Seo; Kang Pa Lee; Sun-Young Park; Sang-Hyun Ahn
Journal:  Phys Act Nutr       Date:  2020-09-30

Review 2.  Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders.

Authors:  Ping Ren; Yuquan Zhang; Yan Huang; Yingli Yang; Ming Jiang
Journal:  Clin Med Insights Oncol       Date:  2015-04-27

Review 3.  Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation.

Authors:  Hongyan Zhao; Ning Zhao; Peng Zheng; Xiaohong Xu; Meijie Liu; Dan Luo; Huihui Xu; Dahong Ju
Journal:  J Immunol Res       Date:  2018-02-20       Impact factor: 4.818

Review 4.  Natural Products from Chinese Medicines with Potential Benefits to Bone Health.

Authors:  Chun-Tao Che; Man Sau Wong; Christopher Wai Kei Lam
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

Review 5.  Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, Phytochemistry, Pharmacokinetics and Safety.

Authors:  Beibei Chen; Lili Wang; Lin Li; Ruyuan Zhu; Haixia Liu; Chenyue Liu; Rufeng Ma; Qiangqiang Jia; Dandan Zhao; Jianzhao Niu; Min Fu; Sihua Gao; Dongwei Zhang
Journal:  Molecules       Date:  2017-09-05       Impact factor: 4.411

Review 6.  Neuroendocrine-Immune Regulatory Network of Eucommia ulmoides Oliver.

Authors:  Yi Zhao; De-Chao Tan; Bo Peng; Lin Yang; Si-Yuan Zhang; Rui-Peng Shi; Cheong-Meng Chong; Zhang-Feng Zhong; Sheng-Peng Wang; Qiong-Lin Liang; Yi-Tao Wang
Journal:  Molecules       Date:  2022-06-08       Impact factor: 4.927

7.  The Interventional Effects of Tubson-2 Decoction on Ovariectomized Rats as Determined by a Combination of Network Pharmacology and Metabolomics.

Authors:  Fan Yang; Xin Dong; Feixiang Ma; Feng Xu; Jie Liu; Jingkun Lu; Chunyan Li; Ren Bu; Peifeng Xue
Journal:  Front Pharmacol       Date:  2020-10-14       Impact factor: 5.810

8.  Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss.

Authors:  Sang-Yong Han; Yun-Kyung Kim
Journal:  Molecules       Date:  2021-12-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.